SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Sold by Wedbush Securities Inc.

Wedbush Securities Inc. decreased its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 7.5% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 10,895 shares of the exchange traded fund’s stock after selling 887 shares during the quarter. Wedbush Securities Inc.’s holdings in SPDR S&P Biotech ETF were worth $956,000 as of its most recent SEC filing.

Several other institutional investors have also recently added to or reduced their stakes in XBI. Quattro Financial Advisors LLC purchased a new position in SPDR S&P Biotech ETF during the second quarter valued at approximately $32,000. Citizens Financial Group Inc RI purchased a new position in SPDR S&P Biotech ETF during the first quarter valued at approximately $36,000. Asset Dedication LLC purchased a new position in SPDR S&P Biotech ETF during the first quarter valued at approximately $41,000. Bedel Financial Consulting Inc. purchased a new position in SPDR S&P Biotech ETF during the first quarter valued at approximately $45,000. Finally, Hall Laurie J Trustee raised its position in SPDR S&P Biotech ETF by 73.3% during the first quarter. Hall Laurie J Trustee now owns 520 shares of the exchange traded fund’s stock valued at $47,000 after acquiring an additional 220 shares in the last quarter.

XBI stock traded down $0.02 during trading on Thursday, hitting $81.23. 121,176 shares of the company traded hands, compared to its average volume of 4,697,604. The stock’s 50-day moving average is $85.55. SPDR S&P Biotech ETF has a 1 year low of $64.38 and a 1 year high of $100.70.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Recommended Story: Death Cross

Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI).

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.